{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,4]],"date-time":"2022-04-04T22:37:10Z","timestamp":1649111830351},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2015,9,29]],"date-time":"2015-09-29T00:00:00Z","timestamp":1443484800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Klin Intensivmed Notfmed"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1007\/s00063-015-0082-3","type":"journal-article","created":{"date-parts":[[2015,9,29]],"date-time":"2015-09-29T09:34:53Z","timestamp":1443519293000},"page":"510-514","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Direkt wirkende orale Antikoagulanzien bei gastrointestinaler Blutung"],"prefix":"10.1007","volume":"110","author":[{"given":"G.","family":"Braun","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Messmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Labenz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Buerke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,9,29]]},"reference":[{"issue":"9921","key":"82_CR1","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/S0140-6736(13)62343-0","volume":"383","author":"CT Ruff","year":"2014","unstructured":"Ruff CT et al (2014) Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials. Lancet 383(9921):955\u2013962","journal-title":"Lancet"},{"key":"82_CR2","doi-asserted-by":"crossref","first-page":"640723","DOI":"10.1155\/2013\/640723","volume":"2013","author":"A G\u00f3mez-Outes","year":"2013","unstructured":"G\u00f3mez-Outes A et al (2013) Dabigatran, Rivaroxaban or Apixaban versus Warfarin in Patients with Nonvalvular Atrial Fibrillation: a systematic review and meta-analysis of subgroups. Thrombosis 2013:640723","journal-title":"Thrombosis"},{"key":"82_CR3","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1056\/NEJMoa1009638","volume":"365","author":"MR Patel","year":"2011","unstructured":"Patel MR et al (2011) Rivaroxaban versus warfarin in patients in nonvalvular atrial fibrillation. N Engl J Med 365:883\u2013891","journal-title":"N Engl J Med"},{"key":"82_CR4","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1056\/NEJMoa0905561","volume":"361","author":"SJ Connolly","year":"2009","unstructured":"Connolly SJ et al (2009) Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med 361:1139\u20131151","journal-title":"N Engl J Med"},{"key":"82_CR5","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1056\/NEJMoa1107039","volume":"365","author":"CB Granger","year":"2011","unstructured":"Granger CB et al (2011) Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med 365:981\u2013992","journal-title":"N Engl J Med"},{"key":"82_CR6","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1053\/j.gastro.2013.02.041","volume":"145","author":"IL Holster","year":"2013","unstructured":"Holster IL et al (2013) New oral anticoagulants increase risk for gastrointestinal bleeding: a systematic review and meta-analysis. Gastroenterology 145:105\u2013112","journal-title":"Gastroenterology"},{"issue":"6","key":"82_CR7","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1182\/blood-2014-03-563577","volume":"124","author":"J Beyer-Westendorf","year":"2014","unstructured":"Beyer-Westendorf J et al (2014) Rates, management and outcome of rivaroxaban bleeding in daily care: results from the Dresden NOAC registry. Blood 124(6):955\u2013962","journal-title":"Blood"},{"issue":"12","key":"82_CR8","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1182\/blood-2014-04-571232","volume":"124","author":"N Es Van","year":"2014","unstructured":"Van Es N et al (2014) Direct oral anticoagulants compared with vitamin K antagonists for acute venous thromboembolism: evidence from phase 3 trials. Blood 124(12):1968\u20131975","journal-title":"Blood"},{"issue":"15","key":"82_CR9","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1136\/heartjnl-2015-307489","volume":"101","author":"D Caldeira","year":"2015","unstructured":"Caldeira D et al (2015) Non-vitamin K antagonist oral anticoagulants and major bleeding-realted fatality in patients with atrial fibrillation and venous thrombembolism: a systematic review and meta-analysis. Heart 101(15):1204\u20131211. doi:10.1136\/heartjnl-2015-307489","journal-title":"Heart"},{"key":"82_CR10","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1007\/s00063-013-0226-2","volume":"108","author":"A Koch","year":"2013","unstructured":"Koch A, Buendgens L et al (2013) Ursachen, patientenspezifische Risikofaktoren und prognostische Indikatoren bei akuter gastrointestinaler Blutung und intensivmedizinischer Therapieindikation. Eine retrospektive Untersuchung der Jahre 1999\u20132010. Med Klin Intensivmed Notfmed 108:214\u2013222","journal-title":"Med Klin Intensivmed Notfmed"},{"key":"82_CR11","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1007\/s00063-013-0257-8","volume":"108","author":"G Braun","year":"2013","unstructured":"Braun G, Messmann H (2013) Gastrointestinale Blutungen beim kardiologischen Patienten. Med Klin Intensivmed Notfmed 108:628\u2013633","journal-title":"Med Klin Intensivmed Notfmed"},{"key":"82_CR12","unstructured":"Pradaxa\u00ae Fachinformation. http:\/\/www.boehringer-ingelheim.de\/content\/dam\/internet\/opu\/de_DE\/document\/pdf\/Produkte\/Statement_Pradaxa_DE.pdf . Zugegriffen: 11. September 2015"},{"key":"82_CR13","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.acvd.2013.04.009","volume":"106","author":"G Pernod","year":"2013","unstructured":"Pernod G et al (2013) Management of major bleeding complications and emergency surgery in patients on long-term treatment with direct oral anticoagulants, thrombin or factor-Xa inhibitors: proposals of the working group on perioperative haemostasis (GIHP) \u2013 March 2013. Arch Cardiovasc Dis 106:382\u2013393","journal-title":"Arch Cardiovasc Dis"},{"key":"82_CR14","doi-asserted-by":"crossref","unstructured":"Enriquez A et al (2015) Anticoagulation reversal in the era of the non-vitamin K oral anticoagulants. Europace. doi:10.1093\/europace\/euv030","DOI":"10.1093\/europace\/euv030"},{"key":"82_CR15","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1161\/CIRCULATIONAHA.111.029017","volume":"124","author":"ES Eerenberg","year":"2011","unstructured":"Eerenberg ES et al (2011) Reversal of rivaroxaban and dabigatran by prothrombin complex concentrate: a randomized placebo controlled cross over study in healthy subjects. Circulation 124:1573\u20131579","journal-title":"Circulation"},{"key":"82_CR16","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.1182\/blood-2011-11-393587","volume":"119","author":"TE Warketin","year":"2012","unstructured":"Warketin TE et al (2012) Recombinant factor VIIa and hemodialysis to manage massive dabigatran-associated post cardiac surgery bleeding. Blood 119:2172\u20132174","journal-title":"Blood"},{"key":"82_CR17","doi-asserted-by":"crossref","first-page":"259","DOI":"10.2165\/11318170-000000000-00000","volume":"49","author":"J Stangier","year":"2010","unstructured":"Stangier J et al (2010) Influence of renal impairment on the pharmacokinetics and pharmacodynamics of oral dabigatran etexilate: an open label, parallel-group, single- centre study. Clin Pharmacokinet 49:259\u2013268","journal-title":"Clin Pharmacokinet"},{"key":"82_CR18","unstructured":"Xarelto\u00ae Fachinformation. http:\/\/www.bayerhealthcare.at\/html\/pdf\/gi\/Xarelto-15-20mg.pdf . Zugegriffen: 11. September 2015"},{"key":"82_CR19","unstructured":"Eliquis\u00ae Fachinformation. https:\/\/www.pfizer.de\/fileadmin\/produktdatenbank\/pdf\/Eliquis_5mg_FI_01.pdf . Zugegriffen: 11. September 2015"},{"key":"82_CR20","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1136\/gut.38.3.316","volume":"38","author":"TA Rockall","year":"1996","unstructured":"Rockall TA et al (1996) Risk assessment after acute upper gastrointestinal haemorrhage. GUT 38:316\u2013321","journal-title":"GUT"},{"key":"82_CR21","doi-asserted-by":"crossref","first-page":"294","DOI":"10.5482\/ha-2012030004","volume":"32","author":"M Spannagl","year":"2012","unstructured":"Spannagl M, Bauersachs R, Debus ES et al (2012) Therapie mit Dabigatran. Periinterventionelles Management und Interpretation von Gerinnungstests. H\u00e4mostaseologie 32:294\u2013305","journal-title":"H\u00e4mostaseologie"},{"key":"82_CR22","doi-asserted-by":"crossref","first-page":"287","DOI":"10.5482\/ha-2012030001","volume":"32","author":"J Koscielny","year":"2012","unstructured":"Koscielny J, Beyer-Westendorf J, Heymann C von (2012) Blutungsrisiko und Blutungsnotf\u00e4lle unter Rivaroxaban \u2013 periinterventionelles H\u00e4mostasemanagement. H\u00e4mostaseologie 32:287\u2013293","journal-title":"H\u00e4mostaseologie"}],"container-title":["Medizinische Klinik - Intensivmedizin und Notfallmedizin"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00063-015-0082-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00063-015-0082-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00063-015-0082-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T02:29:07Z","timestamp":1558578547000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00063-015-0082-3"}},"subtitle":["Interventionelles Therapiemanagement"],"short-title":[],"issued":{"date-parts":[[2015,9,29]]},"references-count":22,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["82"],"URL":"https:\/\/doi.org\/10.1007\/s00063-015-0082-3","relation":{},"ISSN":["2193-6218","2193-6226"],"issn-type":[{"value":"2193-6218","type":"print"},{"value":"2193-6226","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,9,29]]}}}